Advertisement
Screener

UFP Technologies, Inc. (UFPT) Financing Cash Flow

2.8 / 5 stars · 68/120 Roast Me

UFP Technologies, Inc. Financing Cash Flow

UFP Technologies, Inc. (UFPT) reported Financing Cash Flow of -$26.98 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Cash Flow › Financing Activities

us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06

  • UFP Technologies, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was -$25.36M.
  • UFP Technologies, Inc. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$1.62M.
  • UFP Technologies, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$10.88M.
  • UFP Technologies, Inc. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was -$17.49M, a 109.89% decline year-over-year.
  • UFP Technologies, Inc. net cash provided by (used in) financing activities for fiscal 2025 was -$58.16M, a 138.16% decline from fiscal 2024.
  • UFP Technologies, Inc. net cash provided by (used in) financing activities for fiscal 2024 was $152.39M.
  • UFP Technologies, Inc. net cash provided by (used in) financing activities for fiscal 2023 was -$30.02M.
  • UFP Technologies, Inc. net cash provided by (used in) financing activities for fiscal 2022 was -$25.89M, a 134.97% decline from fiscal 2021.
Period endNet Cash Provided by (Used in) Financing Activities 3 monthNet Cash Provided by (Used in) Financing Activities 6 monthNet Cash Provided by (Used in) Financing Activities 9 monthNet Cash Provided by (Used in) Financing Activities 9 month as first filedNet Cash Provided by (Used in) Financing Activities 12 month
2026-06-30-$25.36M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$26.98M
10-Q · filed 2026-08-06
-$37.86M
derived: sum of 3 quarters · filed 2026-08-06
-$55.35M
derived: sum of 4 quarters · filed 2026-08-06
2026-03-31-$1.62M
10-Q · filed 2026-05-08
-$12.50M
derived: sum of 2 quarters · filed 2026-05-08
-$29.99M
derived: sum of 3 quarters · filed 2026-05-08
-$49.08M
derived: sum of 4 quarters · filed 2026-08-06
2025-12-31-$10.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$28.38M
derived: sum of 2 quarters · filed 2026-02-27
-$47.46M
derived: sum of 3 quarters · filed 2026-08-06
-$58.16M
10-K · filed 2026-02-27
2025-09-30-$17.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$36.57M
derived: sum of 2 quarters · filed 2026-08-06
-$47.27M
10-Q · filed 2025-11-07
-$69.99M
derived: sum of 4 quarters · filed 2026-08-06
2025-06-30-$19.08M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06
-$29.78M
10-Q · filed 2026-08-06
-$52.50M
derived: sum of 3 quarters · filed 2026-08-06
$124.28M
derived: sum of 4 quarters · filed 2026-08-06
2025-03-31-$10.70M
10-Q · filed 2026-05-08
-$33.41M
derived: sum of 2 quarters · filed 2026-05-08
$143.37M
derived: sum of 3 quarters · filed 2026-05-08
$144.41M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31-$22.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
$154.07M
derived: sum of 2 quarters · filed 2026-02-27
$155.11M
derived: sum of 3 quarters · filed 2026-02-27
$152.39M
10-K · filed 2026-02-27
2024-09-30$176.78M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$177.83M
derived: sum of 2 quarters · filed 2025-11-07
$175.11M
10-Q · filed 2025-11-07
$163.87M
derived: sum of 4 quarters · filed 2026-02-27
2024-06-30$1.04M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11
-$1.67M
10-Q · filed 2025-08-11
-$12.92M
derived: sum of 3 quarters · filed 2026-02-27
-$26.93M
derived: sum of 4 quarters · filed 2026-02-27
2024-03-31-$2.72M
10-Q · filed 2025-05-12
-$13.96M
derived: sum of 2 quarters · filed 2026-02-27
-$27.98M
derived: sum of 3 quarters · filed 2026-02-27
-$35.31M
derived: sum of 4 quarters · filed 2026-02-27
2023-12-31-$11.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27
-$25.26M
derived: sum of 2 quarters · filed 2026-02-27
-$32.59M
derived: sum of 3 quarters · filed 2026-02-27
-$30.02M
10-K · filed 2026-02-27
2023-09-30-$14.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
-$21.35M
derived: sum of 2 quarters · filed 2024-11-12
-$18.78M
10-Q · filed 2024-11-12
-$39.50M
derived: sum of 4 quarters · filed 2025-03-03
2023-06-30-$7.34M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09
-$4.76M
10-Q · filed 2024-08-09
-$25.49M
derived: sum of 3 quarters · filed 2025-03-03
-$54.35M
derived: sum of 4 quarters · filed 2025-03-03
2023-03-31$2.57M
10-Q · filed 2024-05-10
-$18.15M
derived: sum of 2 quarters · filed 2025-03-03
-$47.01M
derived: sum of 3 quarters · filed 2025-03-03
-$42.01M
derived: sum of 4 quarters · filed 2025-03-03
2022-12-31-$20.72M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03
-$49.58M
derived: sum of 2 quarters · filed 2025-03-03
-$44.58M
derived: sum of 3 quarters · filed 2025-03-03
-$25.89M
10-K · filed 2025-03-03
2022-09-30-$28.86M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09
-$23.86M
derived: sum of 2 quarters · filed 2023-11-09
-$5.17M
10-Q · filed 2023-11-09
$69.47M
derived: sum of 4 quarters · filed 2024-02-29
2022-06-30$5.00M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09
$23.69M
10-Q · filed 2023-08-09
$98.33M
derived: sum of 3 quarters · filed 2024-02-29
$98.32M
derived: sum of 4 quarters · filed 2024-02-29
2022-03-31$18.68M
10-Q · filed 2023-05-10
$93.33M
derived: sum of 2 quarters · filed 2024-02-29
$93.32M
derived: sum of 3 quarters · filed 2024-02-29
$93.48M
derived: sum of 4 quarters · filed 2024-02-29
2021-12-31$74.64M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2024-02-29
$74.64M
derived: sum of 2 quarters · filed 2024-02-29
$74.79M
derived: sum of 3 quarters · filed 2024-02-29
$74.05M
10-K · filed 2024-02-29
2021-09-30-$4.00K
derived: 10-Q/A 9 month − 10-Q 6 month · filed 2022-11-14
$151.00K
derived: sum of 2 quarters · filed 2022-11-14
-$591.00K
10-Q/A · filed 2022-11-14
-$589.00K
10-Q · filed 2021-11-05
-$782.00K
derived: sum of 4 quarters · filed 2023-03-16
2021-06-30$155.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
-$587.00K
10-Q · filed 2022-08-09
-$778.00K
derived: sum of 3 quarters · filed 2023-03-16
-$783.00K
derived: sum of 4 quarters · filed 2023-03-16
2021-03-31-$742.00K
10-Q · filed 2022-05-10
-$933.00K
derived: sum of 2 quarters · filed 2023-03-16
-$938.00K
derived: sum of 3 quarters · filed 2023-03-16
-$883.00K
derived: sum of 4 quarters · filed 2023-03-16
2020-12-31-$191.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
-$196.00K
derived: sum of 2 quarters · filed 2023-03-16
-$141.00K
derived: sum of 3 quarters · filed 2023-03-16
-$285.00K
10-K · filed 2023-03-16
2020-09-30-$5.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
$50.00K
derived: sum of 2 quarters · filed 2021-11-05
-$94.00K
10-Q · filed 2021-11-05
-$15.19M
derived: sum of 4 quarters · filed 2022-03-14
2020-06-30$55.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
-$89.00K
10-Q · filed 2021-08-06
-$15.19M
derived: sum of 3 quarters · filed 2022-03-14
-$17.49M
derived: sum of 4 quarters · filed 2022-03-14
2020-03-31-$144.00K
10-Q · filed 2021-05-07
-$15.24M
derived: sum of 2 quarters · filed 2022-03-14
-$17.55M
derived: sum of 3 quarters · filed 2022-03-14
-$22.11M
derived: sum of 4 quarters · filed 2022-03-14
2019-12-31-$15.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-14
-$17.40M
derived: sum of 2 quarters · filed 2022-03-14
-$21.96M
derived: sum of 3 quarters · filed 2022-03-14
-$24.95M
10-K · filed 2022-03-14
2019-09-30-$2.31M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06
-$6.87M
derived: sum of 2 quarters · filed 2020-11-06
-$9.85M
10-Q · filed 2020-11-06
-$18.57M
derived: sum of 4 quarters · filed 2021-03-12
2019-06-30-$4.56M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
-$7.55M
10-Q · filed 2020-08-07
-$16.26M
derived: sum of 3 quarters · filed 2021-03-12
-$21.67M
derived: sum of 4 quarters · filed 2021-03-12
2019-03-31-$2.99M
10-Q · filed 2020-05-08
-$11.70M
derived: sum of 2 quarters · filed 2021-03-12
-$17.11M
derived: sum of 3 quarters · filed 2021-03-12
-$26.23M
derived: sum of 4 quarters · filed 2021-03-12
2018-12-31-$8.71M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12
-$14.12M
derived: sum of 2 quarters · filed 2021-03-12
-$23.24M
derived: sum of 3 quarters · filed 2021-03-12
$26.27M
10-K · filed 2021-03-12
2018-09-30-$5.41M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08
-$14.53M
derived: sum of 2 quarters · filed 2019-11-08
$34.98M
10-Q · filed 2019-11-08
$34.76M
derived: sum of 4 quarters · filed 2020-03-13
2018-06-30-$9.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09
$40.39M
10-Q · filed 2019-08-09
$40.16M
derived: sum of 3 quarters · filed 2020-03-13
$40.22M
derived: sum of 4 quarters · filed 2020-03-13
2018-03-31$49.51M
10-Q · filed 2019-05-10
$49.28M
derived: sum of 2 quarters · filed 2020-03-13
$49.34M
derived: sum of 3 quarters · filed 2020-03-13
$49.32M
derived: sum of 4 quarters · filed 2020-03-13
2017-12-31-$226.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13
-$169.00K
derived: sum of 2 quarters · filed 2020-03-13
-$191.00K
derived: sum of 3 quarters · filed 2020-03-13
-$475.00K
10-K · filed 2020-03-13
2017-09-30$57.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09
$35.00K
derived: sum of 2 quarters · filed 2018-11-09
-$249.00K
10-Q · filed 2018-11-09
-$616.00K
derived: sum of 4 quarters · filed 2019-03-15
2017-06-30-$22.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09
-$306.00K
10-Q · filed 2018-08-09
-$673.00K
derived: sum of 3 quarters · filed 2019-03-15
2017-03-31-$284.00K
10-Q · filed 2018-05-10
-$651.00K
derived: sum of 2 quarters · filed 2019-03-15
2016-12-31-$367.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15
-$559.00K
10-K · filed 2019-03-15
2016-09-30-$192.00K
10-Q · filed 2017-11-09
2015-12-31-$1.08M
10-K · filed 2018-03-16
2011-06-30-$1.51M
10-Q · filed 2011-08-10
2010-06-30$87.29K
10-Q · filed 2011-08-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
Inspire Medical Systems, Inc. (INSP)United States$1.990B9.55
NovoCure Ltd (NVCR)$1.886B-11.87
LEMAITRE VASCULAR INC (LMAT)United States$1.848B33.37
KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)United States$1.535B-9.02
Alphatec Holdings, Inc. (ATEC)United States$1.531B-12.14
AtriCure, Inc. (ATRC)United States$3.089B
INTEGRA LIFESCIENCES HOLDINGS CORP (IART)United States$1.234B-193.02
ARTIVION, INC. (AORT)United States$1.123B-345.09
IRADIMED CORP (IRMD)United States$1.089B52.92
TANDEM DIABETES CARE INC (TNDM)United States$1.059B-16.57